Ivan Vrhovec

Biochemistry, Genetics and Molecular Biology · Life Sciences

18h-index1.1kcitations45works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protease and Inhibitor Mechanisms(28), Cell Adhesion Molecules Research(12), Bone health and treatments(7), Peptidase Inhibition and Analysis(6), Coagulation, Bradykinin, Polyphosphates, and Angioedema(5)

Publications45 total

Resnica o specifičnem antigenu prostate
DiRROS repository (University of Maribor)·2019Open Access
Prognostic and predictive value of cathepsins D and L in operable breast cancer patients.
PubMed·2005· 23 cited
PAI-1 and PAI-2 as predictive factors in breast cancer
European Journal of Cancer Supplements·2004
Urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 and type 2 in stage I malignant melanoma.
PubMed·2003· 19 cited
Prognostic and Predictive value of the Urokinase-Type Plasminogen Activator (uPA) and Its Inhibitors PAI-1 and PAI-2 in Operable Breast Cancer
The International Journal of Biological Markers·2003· 16 citedOpen Access
Prognostic and predictive value of the urokinase-type plasminogen activator (uPA) and its inhibitors PAI-1 and PAI-2 in operable breast cancer
The International Journal of Biological Markers·2003· 21 cited
Cathepsin D content in endometrial carcinoma
2002
Prognostic Value of the Urokinase-Type Plasminogen Activator, and its Inhibitors and Receptor in Breast Cancer Patients
Clinical Breast Cancer·2002· 45 cited
Prognostic Value of Plasminogen Activator Inhibitors in Breast Cancer
The International Journal of Biological Markers·2002· 18 citedOpen Access
Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients
Cancer Detection and Prevention·2002· 60 cited
Cysteine proteinase inhibitors stefin A and stefin B in operable carcinoma of the head and neck
DiRROS repository (University of Maribor)·2002Open Access
Prognostic value of plasminogen activator inhibitors in breast cancer
The International Journal of Biological Markers·2002· 7 cited
Prognostic Significance of Plasminogen Activator Inhibitor-1 in Breast Cancer, with Special Emphasis on Locoregional Recurrence-Free Survival
The International Journal of Biological Markers·2002· 7 cited
Prognostic significance of plasminogen activator inhibitor-1 in breast cancer, with special emphasis on locoregional recurrence-free survival
The International Journal of Biological Markers·2002· 7 cited
Glutathione and glutathione S-transferases as early markers for ovarian carcinomas: case series.
PubMed·2001· 18 cited
Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck.
PubMed·2001· 19 cited
Plasminogen activator inhibitor type 2: potential prognostic factor for endometrial carcinomas.
PubMed·2001· 15 cited
Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck.
PubMed·2001· 19 cited
Cathepsin D expression in early cutaneous malignant melanoma
International Journal of Dermatology·2000· 26 cited
Decreased cortisol secretion by adrenal glands perfused with the P-glycoprotein inhibitor valspodar and mitotane or doxorubicin
Anti-Cancer Drugs·2000· 6 cited
page 1 of 3Next →

Frequent Co-authors

J Škrk(20), Tanja Čufer(12), Maja Osmak(9), Primož Strojan(8), Marjan Budihna(8), Lojze Šmid(8), Simona Borštnar(8), Janko Kos(7), Branka Svetic(7), Marija Abramić(6), Rastko Golouh(5), Damir Babić(5), Duško Miličić(4), Marija Pfeifer(4), Branimir I. Šikić(4), Borut Štabuc(3), Marta Krašovec(3), Vito Türk(3), Z Rudolf(3), Tamara T. Lah(3)